IL254511A0 - Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell library - Google Patents
Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell libraryInfo
- Publication number
- IL254511A0 IL254511A0 IL254511A IL25451117A IL254511A0 IL 254511 A0 IL254511 A0 IL 254511A0 IL 254511 A IL254511 A IL 254511A IL 25451117 A IL25451117 A IL 25451117A IL 254511 A0 IL254511 A0 IL 254511A0
- Authority
- IL
- Israel
- Prior art keywords
- cell
- specific
- mhc
- immunogenic
- library
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/7051—T-cell receptor (TcR)-CD3 complex
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15159212 | 2015-03-16 | ||
| PCT/EP2016/055518 WO2016146618A1 (en) | 2015-03-16 | 2016-03-15 | Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell library |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL254511A0 true IL254511A0 (en) | 2017-11-30 |
| IL254511B IL254511B (en) | 2021-12-01 |
Family
ID=52669552
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL254511A IL254511B (en) | 2015-03-16 | 2017-09-14 | Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell library |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11001830B2 (en) |
| EP (1) | EP3271382B1 (en) |
| JP (1) | JP6944876B2 (en) |
| KR (1) | KR102668219B1 (en) |
| CN (1) | CN107636152B (en) |
| AU (1) | AU2016232280B2 (en) |
| CA (1) | CA2979493A1 (en) |
| DK (1) | DK3271382T3 (en) |
| ES (1) | ES2790725T3 (en) |
| HK (1) | HK1248736A1 (en) |
| IL (1) | IL254511B (en) |
| SG (1) | SG11201707540QA (en) |
| WO (1) | WO2016146618A1 (en) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8877206B2 (en) | 2007-03-22 | 2014-11-04 | Pds Biotechnology Corporation | Stimulation of an immune response by cationic lipids |
| US9789129B2 (en) | 2008-04-17 | 2017-10-17 | Pds Biotechnology Corporation | Stimulation of an immune response by enantiomers of cationic lipids |
| TWI672149B (en) | 2012-09-21 | 2019-09-21 | 美商Ｐｄｓ生技公司 | Improved vaccine compositions and methods of use |
| AU2016354590B2 (en) | 2015-11-13 | 2023-11-23 | Pds Biotechnology Corporation | Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy |
| US11293021B1 (en) | 2016-06-23 | 2022-04-05 | Inscripta, Inc. | Automated cell processing methods, modules, instruments, and systems |
| US11072660B2 (en) | 2016-10-03 | 2021-07-27 | Juno Therapeutics, Inc. | HPV-specific binding molecules |
| CN110035765B (en) | 2016-10-05 | 2024-04-02 | Pds生物科技公司 | Novel HPV16 non-HLA restricted T cell vaccines, compositions, and methods of use thereof |
| US20190240257A1 (en) * | 2016-10-13 | 2019-08-08 | The Johns Hopkins University | Compositions and methods for identifying functional anti-tumor t cell responses |
| ES2900151T3 (en) | 2016-11-07 | 2022-03-16 | Genovie Ab | A two-part device for T0 cell receptor synthesis and stable genomic integration in TCR-presenting cells |
| CA3038917A1 (en) * | 2016-11-07 | 2018-05-11 | Genovie Ab | An engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens |
| EP3354658A1 (en) * | 2017-01-25 | 2018-08-01 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Novel t cell receptors and immune therapy using the same for the treatment of cancer and infectious diseases |
| US9982279B1 (en) | 2017-06-23 | 2018-05-29 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| US10011849B1 (en) | 2017-06-23 | 2018-07-03 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| SI3645719T1 (en) | 2017-06-30 | 2022-07-29 | Inscripta, Inc., | Automated cell processing methods, modules, instruments, and systems |
| AU2018345539A1 (en) * | 2017-10-03 | 2020-04-16 | Editas Medicine, Inc. | HPV-specific binding molecules |
| GB201719169D0 (en) | 2017-11-20 | 2018-01-03 | Univ College Cardiff Consultants Ltd | Novel T-cell receptor and ligand |
| WO2019140278A1 (en) * | 2018-01-11 | 2019-07-18 | Fred Hutchinson Cancer Research Center | Immunotherapy targeting core binding factor antigens |
| WO2019145792A1 (en) * | 2018-01-24 | 2019-08-01 | The Council Of The Queensland Institute Of Medical Research | Hpv immunotherapy |
| SG11202009284TA (en) | 2018-04-05 | 2020-10-29 | Juno Therapeutics Inc | T cell receptors and engineered cells expressing same |
| WO2019200004A1 (en) | 2018-04-13 | 2019-10-17 | Inscripta, Inc. | Automated cell processing instruments comprising reagent cartridges |
| US10557216B2 (en) | 2018-04-24 | 2020-02-11 | Inscripta, Inc. | Automated instrumentation for production of T-cell receptor peptide libraries |
| US10858761B2 (en) | 2018-04-24 | 2020-12-08 | Inscripta, Inc. | Nucleic acid-guided editing of exogenous polynucleotides in heterologous cells |
| US10508273B2 (en) | 2018-04-24 | 2019-12-17 | Inscripta, Inc. | Methods for identifying selective binding pairs |
| WO2019217831A1 (en) | 2018-05-11 | 2019-11-14 | Memorial Sloan-Kettering Cancer Center | Methods for identifying antigen-specific t cell receptors |
| CN114854720A (en) | 2018-06-30 | 2022-08-05 | 因思科瑞普特公司 | Apparatus, modules and methods for improved detection of editing sequences in living cells |
| US11142740B2 (en) | 2018-08-14 | 2021-10-12 | Inscripta, Inc. | Detection of nuclease edited sequences in automated modules and instruments |
| US10532324B1 (en) | 2018-08-14 | 2020-01-14 | Inscripta, Inc. | Instruments, modules, and methods for improved detection of edited sequences in live cells |
| JP7328631B2 (en) * | 2018-08-24 | 2023-08-17 | Ｒｅｐｅｒｔｏｉｒｅ Ｇｅｎｅｓｉｓ株式会社 | Method for analyzing functional subunit pair genes of T-cell receptors and B-cell receptors |
| AU2019363487A1 (en) | 2018-08-30 | 2021-04-15 | Inscripta, Inc. | Improved detection of nuclease edited sequences in automated modules and instruments |
| US10604746B1 (en) | 2018-10-22 | 2020-03-31 | Inscripta, Inc. | Engineered enzymes |
| US11214781B2 (en) | 2018-10-22 | 2022-01-04 | Inscripta, Inc. | Engineered enzyme |
| KR102251584B1 (en) * | 2018-11-21 | 2021-05-14 | 가톨릭대학교 산학협력단 | Method for measuring and predicting antigen-specific T cell response restricted by HLA molecules |
| US10815467B2 (en) | 2019-03-25 | 2020-10-27 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| US11001831B2 (en) | 2019-03-25 | 2021-05-11 | Inscripta, Inc. | Simultaneous multiplex genome editing in yeast |
| CN110128528B (en) * | 2019-04-28 | 2020-04-03 | 天津亨佳生物科技发展有限公司 | Specific T cell receptor aiming at EGFR L858R gene mutation and application thereof |
| WO2020247587A1 (en) | 2019-06-06 | 2020-12-10 | Inscripta, Inc. | Curing for recursive nucleic acid-guided cell editing |
| US10920189B2 (en) | 2019-06-21 | 2021-02-16 | Inscripta, Inc. | Genome-wide rationally-designed mutations leading to enhanced lysine production in E. coli |
| US10927385B2 (en) | 2019-06-25 | 2021-02-23 | Inscripta, Inc. | Increased nucleic-acid guided cell editing in yeast |
| EP3786178A1 (en) | 2019-08-30 | 2021-03-03 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Tcr constructs specific for ebv-derived antigens |
| WO2021102059A1 (en) | 2019-11-19 | 2021-05-27 | Inscripta, Inc. | Methods for increasing observed editing in bacteria |
| KR20220110778A (en) | 2019-12-10 | 2022-08-09 | 인스크립타 인코포레이티드 | Novel MAD nuclease |
| US10704033B1 (en) | 2019-12-13 | 2020-07-07 | Inscripta, Inc. | Nucleic acid-guided nucleases |
| JP2023507566A (en) | 2019-12-18 | 2023-02-24 | インスクリプタ， インコーポレイテッド | Cascade/dCas3 complementation assay for in vivo detection of nucleic acid-guided nuclease-edited cells |
| CN111180071B (en) * | 2019-12-31 | 2022-02-08 | 四川大学 | Method and device for calculating relationship between high-risk HPV type and cervical cancer pre-lesion stage |
| US10689669B1 (en) | 2020-01-11 | 2020-06-23 | Inscripta, Inc. | Automated multi-module cell processing methods, instruments, and systems |
| KR20220133257A (en) | 2020-01-27 | 2022-10-04 | 인스크립타 인코포레이티드 | Electroporation modules and instruments |
| CN111429965B (en) * | 2020-03-19 | 2023-04-07 | 西安交通大学 | T cell receptor corresponding epitope prediction method based on multiconnector characteristics |
| AU2021243742A1 (en) * | 2020-03-23 | 2022-11-10 | The Council Of The Queensland Institute Of Medical Research | Compositions and methods for targeting HPV-infected cells |
| US20210332388A1 (en) | 2020-04-24 | 2021-10-28 | Inscripta, Inc. | Compositions, methods, modules and instruments for automated nucleic acid-guided nuclease editing in mammalian cells |
| US11787841B2 (en) | 2020-05-19 | 2023-10-17 | Inscripta, Inc. | Rationally-designed mutations to the thrA gene for enhanced lysine production in E. coli |
| CN111574615A (en) * | 2020-05-23 | 2020-08-25 | 湖南源品细胞生物科技有限公司 | TCR enrichment clone type and acquisition method and application thereof |
| WO2021237932A1 (en) * | 2020-05-23 | 2021-12-02 | 湖南源品细胞生物科技有限公司 | Tcr enriched clonotypes and acquisition method and application therefor |
| WO2021243695A1 (en) * | 2020-06-05 | 2021-12-09 | Guangdong Tcrcure Biopharma Technology Co., Ltd. | Tcr-t cell therapy targeting epstein-barr virus |
| CN111647070B (en) * | 2020-06-17 | 2022-06-03 | 深圳豪石生物科技有限公司 | T cell receptor or antigen binding fragment thereof and application |
| US11299731B1 (en) | 2020-09-15 | 2022-04-12 | Inscripta, Inc. | CRISPR editing to embed nucleic acid landing pads into genomes of live cells |
| WO2022086185A1 (en) * | 2020-10-20 | 2022-04-28 | 연세대학교 산학협력단 | Method for identifying tcr-antigen specificity using single cell analysis |
| US11512297B2 (en) | 2020-11-09 | 2022-11-29 | Inscripta, Inc. | Affinity tag for recombination protein recruitment |
| CN113999815A (en) * | 2020-12-08 | 2022-02-01 | 深圳市人民医院 | Establishment method of TCR-T cell targeting HPV16 related cervical cancer |
| CN112501269B (en) * | 2020-12-15 | 2022-02-18 | 清华大学 | Method for rapidly identifying high-affinity TCR antigen cross-reactivity |
| US20240060042A1 (en) * | 2020-12-22 | 2024-02-22 | National University Of Singapore | Artificial antigen-presenting cell |
| EP4271802A1 (en) | 2021-01-04 | 2023-11-08 | Inscripta, Inc. | Mad nucleases |
| EP4274890A1 (en) | 2021-01-07 | 2023-11-15 | Inscripta, Inc. | Mad nucleases |
| US11884924B2 (en) | 2021-02-16 | 2024-01-30 | Inscripta, Inc. | Dual strand nucleic acid-guided nickase editing |
| EP4091627A1 (en) | 2021-05-21 | 2022-11-23 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Tcr constructs specific for magea4-derived epitopes |
| CN117106061B (en) * | 2022-01-27 | 2024-05-31 | 上海市第一人民医院 | TCR (T cell receptor) targeting cytomegalovirus antigen, T cell expressing TCR and application of TCR |
| CN116199766B (en) * | 2022-06-22 | 2024-03-12 | 清华大学 | Methods of screening TCRs and isolated TCRs thereof |
| EP4299734A1 (en) * | 2022-07-01 | 2024-01-03 | ETH Zurich | Cell line for discovering tcr antigens and uses thereof |
| EP4328239A1 (en) | 2022-08-26 | 2024-02-28 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Immunotherapeutics based on magea1-derived epitopes |
| CN117736301B (en) * | 2022-12-23 | 2024-06-18 | 上海市第一人民医院 | TCR targeting cytomegalovirus pp65, T cell expressing same and application |
| CN117736300A (en) * | 2022-12-26 | 2024-03-22 | 上海市第一人民医院 | T cell receptor targeting cytomegalovirus pp65, T cell expressing same and application |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997046256A1 (en) * | 1996-05-23 | 1997-12-11 | The Scripps Research Institute | Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells |
| US6500641B1 (en) * | 1999-05-06 | 2002-12-31 | Wake Forest University School Of Medicine | Compositions and methods for identifying antigens which elicit an immune response |
| US7026443B1 (en) * | 1999-12-10 | 2006-04-11 | Epimmune Inc. | Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions |
| JP2005533855A (en) * | 2002-07-24 | 2005-11-10 | インターツェル・アクチェンゲゼルシャフト | An antigen encoded by another reading frame from a pathogenic virus. |
| US7378234B2 (en) * | 2002-09-13 | 2008-05-27 | Intercell Ag | Method for isolating hepatitis C virus peptides |
| DK1576967T3 (en) | 2004-03-18 | 2008-01-21 | Pasteur Institut | Recombinant protein carrying epitopes of the human papillomavirus inserted into an adenylate cyclase protein or fragment thereof and its therapeutic use |
| HUE038833T2 (en) * | 2005-08-05 | 2018-11-28 | Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Gesundheit & Umwelt Gmbh | Generation of antigen specific T cells |
| ATE440107T1 (en) * | 2005-09-05 | 2009-09-15 | Immatics Biotechnologies Gmbh | TUMOR-ASSOCIATED PEPTIDES THAT BIND HLA CLASS I OR II MOLECULES AND ANTI-TUMOR VACCINES |
| EP1762575A1 (en) * | 2005-09-12 | 2007-03-14 | Ganymed Pharmaceuticals AG | Identification of tumor-associated antigens for diagnosis and therapy |
| WO2011024482A1 (en) | 2009-08-29 | 2011-03-03 | 株式会社バイオメッドコア | Method for measurement of ability of inducing antigen-specific t cells |
| ME02810B (en) * | 2010-09-20 | 2018-01-20 | Biontech Cell & Gene Therapies Gmbh | Antigen-specific t cell receptors and t cell epitopes |
| WO2012044999A2 (en) * | 2010-10-01 | 2012-04-05 | Ludwig Institute For Cancer Research Ltd. | Reversible protein multimers, methods for their production and use |
| EP3262196B1 (en) | 2015-02-24 | 2020-12-09 | Adaptive Biotechnologies Corp. | Method for determining hla status using immune repertoire sequencing |
-
2016
- 2016-03-15 DK DK16713750.4T patent/DK3271382T3/en active
- 2016-03-15 WO PCT/EP2016/055518 patent/WO2016146618A1/en active Application Filing
- 2016-03-15 JP JP2017549029A patent/JP6944876B2/en active Active
- 2016-03-15 ES ES16713750T patent/ES2790725T3/en active Active
- 2016-03-15 US US15/558,765 patent/US11001830B2/en active Active
- 2016-03-15 CN CN201680028229.3A patent/CN107636152B/en active Active
- 2016-03-15 AU AU2016232280A patent/AU2016232280B2/en active Active
- 2016-03-15 EP EP16713750.4A patent/EP3271382B1/en active Active
- 2016-03-15 CA CA2979493A patent/CA2979493A1/en active Pending
- 2016-03-15 KR KR1020177029522A patent/KR102668219B1/en active IP Right Grant
- 2016-03-15 SG SG11201707540QA patent/SG11201707540QA/en unknown
-
2017
- 2017-09-14 IL IL254511A patent/IL254511B/en unknown
-
2018
- 2018-07-04 HK HK18108647.0A patent/HK1248736A1/en unknown
-
2021
- 2021-05-06 US US17/313,761 patent/US20210261947A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20210261947A1 (en) | 2021-08-26 |
| EP3271382A1 (en) | 2018-01-24 |
| CN107636152B (en) | 2021-09-21 |
| JP6944876B2 (en) | 2021-10-06 |
| AU2016232280A1 (en) | 2017-10-12 |
| JP2018509911A (en) | 2018-04-12 |
| HK1248736A1 (en) | 2018-10-19 |
| US11001830B2 (en) | 2021-05-11 |
| EP3271382B1 (en) | 2020-02-12 |
| WO2016146618A1 (en) | 2016-09-22 |
| IL254511B (en) | 2021-12-01 |
| CN107636152A (en) | 2018-01-26 |
| KR20170126500A (en) | 2017-11-17 |
| AU2016232280B2 (en) | 2018-05-31 |
| CA2979493A1 (en) | 2016-09-22 |
| DK3271382T3 (en) | 2020-05-04 |
| KR102668219B1 (en) | 2024-05-28 |
| ES2790725T3 (en) | 2020-10-29 |
| SG11201707540QA (en) | 2017-10-30 |
| US20180073013A1 (en) | 2018-03-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1248736A1 (en) | Method of detecting new immunogenic t cell epitopes and isolating new antigen-specific t cell receptors by means of an mhc cell library | |
| HK1246852A1 (en) | Predicting t cell epitopes useful for vaccination | |
| HUE056387T2 (en) | Method for inducing antigen specific cd8 positive t cells | |
| HK1224340A1 (en) | Method for isolating and proliferating self-tumor antigen-specific cd8 t cells cd8 t | |
| IL256511B (en) | An immuno-responsive cell expressing a chimeric antigen receptor and a chimeric costimulatory receptor | |
| EP3277294C0 (en) | Method of identifying human compatible t cell receptors specific for an antigenic target | |
| HK1256130A1 (en) | T cells for expression of chimeric antigen receptors and other receptors | |
| EP3236409A4 (en) | System for predicting residual lifespan of fire-damaged concrete structure and method therefor | |
| HK1243206A1 (en) | Method and system for geolocation verification of resources | |
| EP3010157A4 (en) | Method for detecting electric quantity of device, device and system | |
| PL3123254T3 (en) | Method of optimized global management of an energy network of an aircraft and corresponding device | |
| EP3134735A4 (en) | Methods of measuring antigen-specific t cells | |
| AP2016009458A0 (en) | Grouted rock support testing apparatus and method | |
| HK1232288A1 (en) | Method for measuring reactivity of fviii fviii | |
| EP3025404A4 (en) | Method and apparatus of secure charging for device-to-device service | |
| GB2560833B (en) | System and method for foundation of wellheads | |
| GB201401892D0 (en) | System and method for measuring properties of a charges particle beam | |
| SG11201706418QA (en) | Method for antigen loading of dendritic cells and vaccine | |
| DK3224894T3 (en) | Method of symmetry of an energy storage system | |
| EP3211583A4 (en) | Method for estimating earthquake resistance magnitude of existing structure and system therefor | |
| IL234216A0 (en) | Method and system for causing explosions inside tunnels | |
| GB201502823D0 (en) | Insulation support and method for construction | |
| GB201418590D0 (en) | Improved method of radon gas control for buildings | |
| GB201316368D0 (en) | Method of, and apparatus for, detecting leaks from underwater sources |